I bought into this company a couple of weeks ago. Like BeauJester, it caught my eye in IBD. The only negative I could see with them was that sales and earnings growth were not at 25% as recommended in MFIG (Sales: 11%; Earnings: 6.8%). Everything else looked very good with 11% profit margin, 45% insider investment, and positive cash flow. Their Fool Ratio is .42, and at least one broker recommends it as a strong buy (Zacks, 7/4/97).As an investor, I intend to keep up on news and EPS, and will post anything of note to this board.scamp
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates,